Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP440323.RA4DrS5mzM7TvMdE-SEQj0dKviVBoys24_hXhtBY-0dr4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP440323.RA4DrS5mzM7TvMdE-SEQj0dKviVBoys24_hXhtBY-0dr4130_assertion type Assertion NP440323.RA4DrS5mzM7TvMdE-SEQj0dKviVBoys24_hXhtBY-0dr4130_head.
- NP440323.RA4DrS5mzM7TvMdE-SEQj0dKviVBoys24_hXhtBY-0dr4130_assertion description "[Nearly half of these tumors are nonhyperdiploid and mostly have immunoglobulin H (IgH) translocations that involve 5 recurrent chromosomal loci, including 11q13 (cyclin D1), 6p21 (cyclin D3), 4p16 (fibroblast growth factor receptor 3 [FGFR3] and multiple myeloma SET domain [MMSET]), 16q23 (c-maf), and 20q11 (mafB).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP440323.RA4DrS5mzM7TvMdE-SEQj0dKviVBoys24_hXhtBY-0dr4130_provenance.
- NP440323.RA4DrS5mzM7TvMdE-SEQj0dKviVBoys24_hXhtBY-0dr4130_assertion evidence source_evidence_literature NP440323.RA4DrS5mzM7TvMdE-SEQj0dKviVBoys24_hXhtBY-0dr4130_provenance.
- NP440323.RA4DrS5mzM7TvMdE-SEQj0dKviVBoys24_hXhtBY-0dr4130_assertion SIO_000772 15090448 NP440323.RA4DrS5mzM7TvMdE-SEQj0dKviVBoys24_hXhtBY-0dr4130_provenance.
- NP440323.RA4DrS5mzM7TvMdE-SEQj0dKviVBoys24_hXhtBY-0dr4130_assertion wasDerivedFrom befree-2016 NP440323.RA4DrS5mzM7TvMdE-SEQj0dKviVBoys24_hXhtBY-0dr4130_provenance.
- NP440323.RA4DrS5mzM7TvMdE-SEQj0dKviVBoys24_hXhtBY-0dr4130_assertion wasGeneratedBy ECO_0000203 NP440323.RA4DrS5mzM7TvMdE-SEQj0dKviVBoys24_hXhtBY-0dr4130_provenance.